Clinical features, treatment and prognosis of MuSK antibody-associated myasthenia gravis in Northwest China: a single-centre retrospective cohort study
Abstract Background and purpose To summarize the clinical characteristics of patients with muscle-specific kinase antibody-associated myasthenia gravis (MuSK-MG) and to evaluate the therapeutic responses to different treatment regimes. Methods Eighteen MuSK-MG patients admitted in our department bet...
Guardado en:
Autores principales: | Sijia Zhao, Kai Zhang, Kaixi Ren, Jiarui Lu, Chao Ma, Cong Zhao, Zhuyi Li, Jun Guo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/06a2091176234cacbe2f0df117658544 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Miastenia gravis refractaria con buena respuesta a rituximab. Caso clínico
por: Suárez H.,Felipe, et al.
Publicado: (2020) -
Efficacy and Safety of Immunotherapies in Refractory Myasthenia Gravis: A Systematic Review and Meta-Analysis
por: Xuelin Feng, et al.
Publicado: (2021) -
Fetal Surveillance in Pregnancies with Myasthenia Gravis
por: Brîndușa Ana Cimpoca-Raptis, et al.
Publicado: (2021) -
Research of antibodies to the acetylcholine receptors in patients with myasthenia gravis
por: T. V. Romanova
Publicado: (2013) -
PLASMAPHERESIS IN THE TREATMENT OF MYASTHENIA GRAVIS: OUTCOME AND COMPLICATIONS
por: Maryam Abbas, et al.
Publicado: (2021)